San Jose, California (ots/PRNewswire) - - Facilitates Low-cost, Easy Evaluation of CAP Capabilities Atmel(R) Corporation (Nasdaq: ATML) today announced its AT91CAP7A-STK Starter Kit for the evaluation of its ARM7(TM)-based CAP(TM) family of customizable microcontrollers. CAP7 customizable MCUs allow designers to migrate ARM7-plus-FPGA designs to a ...
Amsterdam (ots/PRNewswire) - Avantium announced today that it has entered into a master services agreement with Chevron Energy Technology Company for the application of high-throughput technologies in the development of catalysts in the oil and gas field. Avantium specializes in high-throughput methodologies that enable scientists to conduct parallel experiments ...
Society for Cardiovascular Angiography and Interventions (SCAI)
Washington (ots/PRNewswire) - - At One Year, Angioplasty and Stenting Matches Bypass Surgery for Safety and Effectiveness in Patients with Complex Medical Condition Patients with both diabetes and advanced blockages in at least three heart vessels will find good news in new findings announced today from the CARDia trial, says The Society for ...
Society for Cardiovascular Angiography and Interventions (SCAI)
Washington (ots/PRNewswire) - - One-Year Data Find Angioplasty and Stenting Safe and Effective in Patients for Whom Standard Therapy Has Been Open-Heart Surgery Data announced today from the landmark SYNTAX trial indicate that patients with very complex coronary artery disease can safely choose to be treated with angioplasty and drug-eluting stents rather ...
Munich, Germany (ots/PRNewswire) - Biosensors International Group, Ltd ("Biosensors", "Company"), (Bloomberg: BIG:SP), (Singapore:B20) today announced that a next-generation drug-eluting stent, developed by Biosensors, has demonstrated equal safety and efficacy as compared to Johnson & Johnson's industry leading ...
Montpellier, France (ots/PRNewswire) - The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean ...
Munich, Germany (ots/PRNewswire) - - TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care MUNICH, Germany, August 31 /PRNewswire/ -- - For non-US Healthcare Media The ...
Cork, Ireland (ots/PRNewswire) - -INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside ...
Astellas Pharma Europe Limited
Staines, England (ots/PRNewswire) - - Not for distribution in the United Kingdom - Research Adds to Already Demonstrated Efficacy in Adult Population Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment ...
Washington (ots/PRNewswire) - Crude oil prices "could" fall below US$100 per barrel over the next 18 months on slowing worldwide demand and an increase in oil production, Energy Information Administration (EIA) chief Guy Caruso said Tuesday. Caruso made the comment to reporters at the Platts Energy Podium in Washington. "I think [prices] could fall below US$100 a barrel on slowing global demand and rising ...
Laval, Canada (ots/PRNewswire) - The Laval-based firm Algorithme Pharma is pleased to announce that it has achieved its goal of securing a European facility through its acquisition of Simbec Research Ltd in Merthyr Tydfil, Wales. This news comes only six weeks after confirming the purchase of another clinical ...
Calgary, Canada (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) is pleased to announce that the Phase 1b/2a program for the study of RVX-208 in subjects with normal lipids and those with low high-density lipoprotein (HDL) cholesterol has proceeded according to plan. "We are very excited about moving forward into this important 28-day study with RVX-208. Our previous clinical study ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the production availability of its new AT25DF081, the industry's first 8-megabit Serial Flash device capable of operating at 1.8-volts. With a low-voltage operating range of 1.65V to 1.95V, the AT25DF081 operates at the same voltage range as many current and ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICS) (ICX:TSX.V) is pleased to announce the appointment of Mr. Richard Molyneux to the position of Chairman of the Board of Directors. The Company wishes to express its gratitude to the outgoing Chairman, Mr. Mel Smale, who will stay on as a Director. Mr. Smale has been the Chairman of ICS since the Company went public and has served the ...
Indianapolis (ots/PRNewswire) - - Study with duloxetine evaluating long-term pain reduction in treatment of DPNP is first to exceed three months Duloxetine hydrochloride maintained pain reduction in the treatment of diabetic peripheral neuropathic pain (DPNP) for more than six months,(1) according to new ...
Petit-Lancy (ots) - - July retails sales up 28 percent - 220,500 units January-July highest volume in company history - 17 countries up in July, 15 countries with double-digit growth ots Originaltext: Mazda (Suisse) SA Internet: www.presseportal.ch/fr Contact: Mazda (Suisse) SA Giuseppe Loffredo PR Director Tel.: +41/22/719'33'60 E-Mail: gloffredo@mazda.ch Internet: ...
London (ots/PRNewswire) - Platts -- The Organization of the Petroleum Exporting Countries' (OPEC) 13 members boosted their collective crude oil production by 300,000 barrels per day (b/d) in July to average 32.77 million b/d over the month, according to a Platts survey of OPEC and oil industry officials just released. Excluding Iraq, the 12 members bound by ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today that it supports a new text-based information service for digital broadcasting, called Journaline(R), which will be integrated into several shuttle vehicles at the 2008 Summer Olympics in China. This service delivers ...
Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) ...
Premier Muzik International Corporation
Montreal (ots/PRNewswire) - Gino Olivieri, founder of Premier Muzik International Corporation, a Montreal company that administers and redistributes royalties to such artists as Red Hot Chili Peppers, Metallica, Bob Sinclar and Andrea Bocelli, has realized one of his fondest dreams by becoming the winning bidder ...
Vancouver (ots/PRNewswire) - Oremex Resources Inc. (TSX-V: ORM) (the Company) today provided a progress update for the Tejamen Silver Property (Tejamen). The Company has generated significant support for development of Tejamen from State, regional and local officials as well as the commercial, health, educational and regional sectors and the general populace of Tejamen and Nuevo Ideal. In addition, the Federal Minister of Mines has dedicated staff to assist with ...
Mexico City (ots/PRNewswire) - - HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar ...
Mexico City, Mexico (ots/PRNewswire) - - Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008 New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company's once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults ...
Basel, Switzerland (ots/PRNewswire) - - Submission Based on Phase III Study Showing Superior Results for MabThera in Chronic Lymphocytic Leukaemia (CLL) When Added to Standard Chemotherapy Today, Roche submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for the use of its biotechnology drug MabThera (rituximab) as ...
Chicago (ots/PRNewswire) - - Findings lead to decision to start Phase III pivotal study of LY2062430 in 2009 Eli Lilly and Company (NYSE: LLY) today announced interim results of its Phase II study of LY2062430, an investigational anti-amyloid beta monoclonal antibody for the treatment of mild to ...
Calgary (ots/PRNewswire) - - Submission Demonstrates Progress of Plant-Derived Insulin Program Scheduled to Enter the Clinic Later This Year SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it has submitted an Investigational New Drug ...
Paris (ots/PRNewswire) - - Net Income up by 41% - Fourth Consecutive Quarter of Margin Improvement - Debt Reduction of 178 Million Euros - Good Level of Order Intake Valeo's Board of Directors, which met yesterday, approved the consolidated financial summary for the first half 2008. 1st half** Quarterly change in 2008 In million euros 2nd 1st ...
Dar Es Salaam, Tanzania (ots/PRNewswire) - - Partnership Will Modernize All Regional Hospital Laboratories to Improve Access to Care Across the Country At a ceremony today, the Ministry of Health and Social Welfare, United Republic of Tanzania, and Abbott Fund commemorated the latest step in a nationwide ...
Paris (ots/PRNewswire) - On 24 June, Justin Timberlake made an exclusive appearance in Paris for Parfums Givenchy at the press presentation of Givenchy's new men's fragrance. Timberlake is the face of the new scent, which will go on sale in September 2008, and is featured in the two advertising visuals for the brand. Multimedia News Release - http://www.prnewswire.com/mnr/givenchy/34164/ The American star's ...
Paris and Copenhagen, Denmark (ots/PRNewswire) - In a statement following the final results of this year's Tour de France, the two founders of Saxo Bank and joint CEOs, Kim Fournais and Lars Seier Christensen, praised the Team CSC Saxo Bank and said that with this Tour the cycling sport had reached a turning point. "Watching Carlos Sastre in the Yellow Jersey and Andy Schleck in the White, side by side, today, ...